| 1 |
Lazarus JH. Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease[J]. Best Pract Res Clin Endocrinol Metab, 2012, 26(3): 273-279.
|
| 2 |
Bahn RS. Graves' ophthalmopathy[J]. N Engl J Med, 2010, 362(8): 726-738.
|
| 3 |
Saeed P, Tavakoli Rad S, Bisschop P. Dysthyroid Optic Neuropathy[J]. Ophthalmic Plast Reconstr Surg, 2018, 34(4S Suppl 1): S60-S67.
|
| 4 |
骆永恒，李亚军. 甲状腺相关眼病活动性的影像评估[J]. 国际医学放射学杂志, 2015, 38(3): 224-227.
|
| 5 |
Atta HR, Mccreath G, Mckillop JH, et al. Ophthalmopathy in early thyrotoxicosis--relationship to thyroid receptor antibodies and effects of treatment[J]. Scott Med J, 1990, 35(2): 41-44.
|
| 6 |
艾立坤，刘玉华，姜茹欣，等. 甲状腺相关性眼病的A型超声检查及临床分析[J]. 中国斜视与小儿眼科杂志, 2001, 9(1): 4-7.
|
| 7 |
梁雄飞，陈在逢. 彩色多普勒超声在甲状腺相关眼病诊疗中的应用研究[J]. 中国地方病防治杂志, 2017, 32(8): 909-910.
|
| 8 |
Yuksel N, Unal O, Mutlu M, et al. Real-time ultrasound elastographic evaluation of extraocular muscle involvement in Graves' ophthalmopathy[J]. Orbit, 2020, 39(3): 160-164.
|
| 9 |
Chang SH, Papageorgiou KI, Ang M, et al. High-resolution ultrasound as an effective and practical tool to analyze eyebrow profile expansion in thyroid-associated periorbitopathy[J]. Ophthalmic Plast Reconstr Surg, 2013, 29(5): 382-385.
|
| 10 |
Rajabi MT, Papageorgiou K, Taban M, et al. Ultrasonographic motion analysis of lower eyelid compartments in patients with chronic thyroid associated ophthalmopathy[J]. J Curr Ophthalmol, 2017, 29(4): 310-317.
|
| 11 |
Bartalena L, Baldeschi L, Boboridis K, et al. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy[J]. Eur Thyroid J, 2016, 5(1): 9-26.
|
| 12 |
Prummel MF, Suttorp-Schulten MS, Wiersinga WM, et al. A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathy[J]. Ophthalmology, 1993, 100(4): 556-561.
|
| 13 |
Gerding MN, Prummel MF, Wiersinga WM. Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters[J]. Clin Endocrinol (Oxf), 2000, 52(5): 641-646.
|
| 14 |
刘雪清，张爱红，关新林，等. 甲状腺相关眼病球后血管血流动力学分析[J]. 新疆医学, 2015, 4): 425-429.
|
| 15 |
Lesin M, Rogosic V, Vanjaka Rogosic L, et al. Flow Changes in Orbital Vessels Detected with Color Doppler Ultrasound in Patients with Early Dysthyroid Optic Neuropathy[J]. Acta Clin Croat, 2018, 57(2): 301-306.
|
| 16 |
Forbes G, Gorman CA, Brennan MD, et al. Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle[J]. AJNR Am J Neuroradiol, 1986, 7(4): 651-656.
|
| 17 |
Parmar H, Ibrahim M. Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy[J]. Neuroimaging Clin N Am, 2008, 18(3): 527-536.
|
| 18 |
Regensburg NI, Wiersinga WM, Berendschot TT, et al. Densities of orbital fat and extraocular muscles in graves orbitopathy patients and controls[J]. Ophthalmic Plast Reconstr Surg, 2011, 27(4): 236-240.
|
| 19 |
Byun JS, Moon NJ, Lee J K. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy[J]. Graefes Arch Clin Exp Ophthalmol, 2017, 255(2): 413-420.
|
| 20 |
拓秀，信中，闫钟钰, 等. CT眼眶结构定量分析在甲状腺相关性眼病活动性评价中的作用[J]. 眼科, 2018, 27(5): 333-337.
|
| 21 |
Barrett L, Glatt HJ, Burde RM, et al. Optic nerve dysfunction in thyroid eye disease: CT[J]. Radiology, 1988, 167(2): 503-507.
|
| 22 |
Giaconi JA, Kazim M, Rho T, et al. CT scan evidence of dysthyroid optic neuropathy[J]. Ophthalmic Plast Reconstr Surg, 2002, 18(3): 177-182.
|
| 23 |
Birchall D, Goodall KL, Noble JL, et al. Graves ophthalmopathy: intracranial fat prolapse on CT images as an indicator of optic nerve compression[J]. Radiology, 1996, 200(1): 123-127.
|
| 24 |
Tan NYQ, Leong YY, Lang SS, et al. Radiologic Parameters of Orbital Bone Remodeling in Thyroid Eye Disease[J]. Invest Ophthalmol Vis Sci, 2017, 58(5): 2527-2533.
|
| 25 |
刘国浩，杨娜，王志强, 等. 低场MRI在甲状腺相关性眼病的应用及诊断价值分析[J]. 吉林医药学院学报, 2012, 33(6): 389-390.
|
| 26 |
Abdel Razek AA, El-Hadidy M, Moawad ME, et al. Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy[J]. Neuroradiol J, 2017, 30(3): 230-234.
|
| 27 |
Han JS, Seo HS, Lee YH, et al. Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy[J]. Neuroradiology, 2016, 58(12): 1189-1196.
|
| 28 |
姜虹，燕飞，鲜军舫, 等. T2弛豫时间参数图MRI预测Graves眼病活动性的价值[J]. 中华放射学杂志, 2018, 52(9): 655-659.
|
| 29 |
姜虹，燕飞，鲜军舫, 等. T2mappiing MRI评估甲状腺相关性眼病免疫抑制疗效的初步研究[J]. 眼科, 2018, 27(5): 339-343.
|
| 30 |
Das T, Roos JCP, Patterson AJ, et al. T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study[J]. Eye (Lond), 2019, 33(2): 235-243.
|
| 31 |
Tomoaki H, Yasuhiro N, Masahito O. Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy[J]. Clin Ophthalmol, 2016, 10: 721-729.
|
| 32 |
Higashiyama T, Nishida Y, Morino K, et al. Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy[J]. Jpn J Ophthalmol, 2015, 59(2): 124-130.
|
| 33 |
Higashiyama T, Iwasa M, Ohji M. Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity[J]. Sci Rep, 2017, 7(1): 16874.
|
| 34 |
Wu T, Tang DR, Wang F, et al. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy][J]. Zhonghua yan ke za zhi, 2017, 53(6): 430-435.
|
| 35 |
Dodds NI, Atcha AW, Birchall D, et al. Use of high-resolution MRI of the optic nerve in Graves' ophthalmopathy[J]. Br J Radiol, 2009, 82(979): 541-544.
|
| 36 |
Lee H, Lee YH, Suh SI, et al. Characterizing Intraorbital Optic Nerve Changes on Diffusion Tensor Imaging in Thyroid Eye Disease Before Dysthyroid Optic Neuropathy[J]. J Comput Assist Tomogr, 2018, 42(2): 293-298.
|
| 37 |
孙斌. 生长抑素类似物眼眶显像在甲状腺相关性眼病诊疗中的应用[J]. 眼科, 2016, 25(6): 361-364.
|
| 38 |
Sun B, Zhang Z, Dong C, et al. (99)Tc(m)-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy[J]. Eye (Lond), 2017, 31(5): 668-676.
|
| 39 |
刘丹，许雪亮，文丹, 等. 99mTc-DTPA眼眶SPECT/CT对甲状腺相关性眼病炎性活动的评价[J]. 中南大学学报(医学版), 2018, 43(4): 457-461.
|
| 40 |
Szumowski P, Abdelrazek S, Zukowski L, et al. Efficacy of (99m)Tc-DTPA SPECT/CT in diagnosing Orbitopathy in graves' disease[J]. BMC Endocr Disord, 2019, 19(1): 10.
|
| 41 |
蒋承志，李新辉，赵敏, 等. 99mTc-DTPA眼眶SPECT/CT对甲状腺相关性眼病泪腺炎症的评估价值[J]. 中南大学学报(医学版), 2019, 44(3): 322-328.
|